ENTRY       D01441                      Drug
NAME        Imatinib mesylate (USAN);
            Imatinib mesilate (JAN);
            Gleevec (TN);
            Glivec (TN)
PRODUCT     GLEEVEC (Novartis Pharmaceuticals Corporation)
  GENERIC   IMATINIB (Dr.Reddy's Laboratories)
            IMATINIB MESYLATE (American Health Packaging)
            IMATINIB MESYLATE (Amneal Pharmaceuticals LLC)
            IMATINIB MESYLATE (Apotex Corp)
            IMATINIB MESYLATE (Archis Pharma LLC)
            IMATINIB MESYLATE (Areva Pharmaceuticals)
            IMATINIB MESYLATE (Armas Pharmaceuticals)
            IMATINIB MESYLATE (Armas Pharmaceuticals)
            IMATINIB MESYLATE (Ascend Laboratories)
            IMATINIB MESYLATE (Aurobindo Pharma Limited)
            IMATINIB MESYLATE (BluePoint Laboratories)
            IMATINIB MESYLATE (CELLTRION USA)
            IMATINIB MESYLATE (Golden State Medical Supply)
            IMATINIB MESYLATE (Hikma Pharmaceuticals USA)
            IMATINIB MESYLATE (Major Pharmaceuticals)
            IMATINIB MESYLATE (Mylan Institutional)
            IMATINIB MESYLATE (Mylan Pharmaceuticals)
            IMATINIB MESYLATE (QUALLENT PHARMACEUTICALS HEALTH LLC)
            IMATINIB MESYLATE (Qilu Pharmaceutical)
            IMATINIB MESYLATE (Sun Pharmaceutical Industries)
            IMATINIB MESYLATE (Teva Pharmaceuticals USA)
            IMATINIB MESYLATE (Wockhardt USA LLC.)
            IMATINIB MESYLATE (Zydus Lifesciences Limited)
            IMATINIB MESYLATE (Zydus Pharmaceuticals USA)
FORMULA     C29H31N7O. CH4SO3
EXACT_MASS  589.2471
MOL_WEIGHT  589.7084
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG03161  BCR-ABL inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01EA01
            Chemical structure group: DG00710
            Product (DG00710): D01441<JP/US>
EFFICACY    Antineoplastic, Tyrosine kinase inhibitor
  DISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]
            Acute lymphoblastic leukemia (Philadelphia chromosome positive) [DS:H00001]
            Myelodysplastic/myeloproliferative diseases [DS:H02410]
            Mastocytosis [DS:H01511]
            Hypereosinophilic syndrome (FIP1L1-PDGFRA positive) [DS:H01599]
            Chronic eosinophilic leukemia (FIP1L1-PDGFRA positive) [DS:H01590]
            Gastrointestinal stromal tumors (KIT positive) [DS:H01591]
TARGET      BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]
            FIP1L1-PDGFRA [HSA:5156] [KO:K04363]
            KIT (CD117) [HSA:3815] [KO:K05091]
  PATHWAY   hsa04010(3815+5156)  MAPK signaling pathway
            hsa05200(25+3815+5156)  Pathways in cancer
            hsa05220(25)  Chronic myeloid leukemia
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EA BCR-ABL tyrosine kinase inhibitors
                 L01EA01 Imatinib
                  D01441  Imatinib mesylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Imatinib
                D01441  Imatinib mesylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D01441  Imatinib mesylate (USAN); Imatinib mesilate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03161  BCR-ABL inhibitor
                DG00710  Imatinib
                 D01441  Imatinib mesylate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00710  Imatinib
                 D01441  Imatinib mesylate
            Drug classes [BR:br08332]
             Antineoplastic
              DG03161  BCR-ABL inhibitor
               D01441  Imatinib mesylate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                FIP1L1-PDGFRA
                 D01441  Imatinib mesylate (USAN) &lt;JP/US&gt;
                KIT (CD117)
                 D01441  Imatinib mesylate (USAN) &lt;JP/US&gt;
              Non-receptor tyrosine kinases
               ABL family
                BCR-ABL [HSA_VAR:25v1]
                 D01441  Imatinib mesylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01441
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01441
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01441
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01441
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01441
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D01441
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03161  BCR-ABL inhibitor
                DG00710  Imatinib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00710  Imatinib
DBLINKS     CAS: 220127-57-1
            PubChem: 7848504
            ChEBI: 31690
            LigandBox: D01441
            NIKKAJI: J1.337.144J
ATOM        42
            1   C8x C    33.4600  -13.6500
            2   C8y C    33.4600  -12.2500
            3   C8x C    32.2700  -11.5500
            4   C8x C    31.0100  -12.2500
            5   C8y C    31.0100  -13.6500
            6   C8x C    32.2700  -14.3500
            7   C5a C    29.8200  -14.3500
            8   N1b N    28.6300  -13.6500
            9   C8y C    27.4400  -14.3500
            10  C8x C    26.1800  -13.6500
            11  C8y C    24.9900  -14.3500
            12  C8y C    24.9900  -15.7500
            13  C8x C    26.1800  -16.4500
            14  C8x C    27.4400  -15.7500
            15  N1b N    23.8000  -13.7200
            16  C8y C    22.5400  -14.4200
            17  N5x N    21.3500  -13.7200
            18  C8y C    20.1600  -14.4200
            19  C8x C    20.1600  -15.8200
            20  C8x C    21.3500  -16.5200
            21  N5x N    22.5400  -15.8200
            22  C8y C    18.9000  -13.7200
            23  C8x C    18.9000  -12.3200
            24  N5x N    17.7100  -11.6200
            25  C8x C    16.5200  -12.3200
            26  C8x C    16.5200  -13.7200
            27  C8x C    17.7100  -14.4200
            28  C1b C    34.6500  -11.5500
            29  N1y N    35.9100  -12.2500
            30  C1x C    35.9100  -13.6500
            31  C1x C    37.1000  -14.3500
            32  N1y N    38.2900  -13.6500
            33  C1x C    38.2900  -12.2500
            34  C1x C    37.1000  -11.5500
            35  C1a C    39.5500  -14.3500
            36  O5a O    29.8200  -15.7500
            37  C1a C    23.8000  -16.4500
            38  S4a S    34.9300  -16.5900
            39  O1d O    34.9300  -15.1900
            40  O1d O    34.9300  -17.9900
            41  C1a C    33.5300  -16.5900
            42  O1d O    36.3300  -16.5900
BOND        45
            1    18  19 2
            2    19  20 1
            3    20  21 2
            4    21  16 1
            5     3   4 2
            6    18  22 1
            7     4   5 1
            8     5   6 2
            9     6   1 1
            10    9  10 2
            11   10  11 1
            12   22  23 2
            13   23  24 1
            14   24  25 2
            15   25  26 1
            16   26  27 2
            17   27  22 1
            18   11  12 2
            19    2  28 1
            20   12  13 1
            21   28  29 1
            22   13  14 2
            23   14   9 1
            24   11  15 1
            25    5   7 1
            26   29  30 1
            27   30  31 1
            28   31  32 1
            29   32  33 1
            30   33  34 1
            31   34  29 1
            32   15  16 1
            33   32  35 1
            34    7  36 2
            35    7   8 1
            36   12  37 1
            37    1   2 2
            38    8   9 1
            39    2   3 1
            40   16  17 2
            41   17  18 1
            42   38  39 2
            43   38  40 2
            44   38  41 1
            45   38  42 1
///
